American Diabetes Association - 65th Scientific Sessions. PPAR agents.
Erlich
Rebecca
R
Thomson Scientific, Middlesex House, London, UK. rebecca.erlich@thomson.com
D000476:Alkanesulfonates / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D010080:Oxazoles / Q000494:pharmacology / Q000627:therapeutic use; D047492:Peroxisome Proliferator-Activated Receptors / Q000819:agonists / Q000187:drug effects*; D010666:Phenylpropionates / Q000494:pharmacology / Q000627:therapeutic use
D000476:Alkanesulfonates; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D010080:Oxazoles; D047492:Peroxisome Proliferator-Activated Receptors; D010666:Phenylpropionates; C501413:tesaglitazar; D005998:Glycine; C500085:muraglitazar